- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/00 - Drugs for immunological or allergic disorders
Patent holdings for IPC class A61P 37/00
Total number of patents in this class: 7422
10-year publication summary
|
371
|
362
|
336
|
331
|
355
|
487
|
634
|
628
|
506
|
214
|
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 313 |
290 |
| Bristol-myers Squibb Company | 5307 |
133 |
| Novartis AG | 13334 |
123 |
| F. Hoffmann-La Roche AG | 8729 |
116 |
| Genentech, Inc. | 3970 |
75 |
| Incyte Corporation | 805 |
62 |
| Boehringer Ingelheim International GmbH | 4952 |
60 |
| Merck Patent GmbH | 6561 |
58 |
| Merck Sharp & Dohme Corp. | 6011 |
53 |
| Glaxo Group Limited | 4873 |
51 |
| Glaxosmithkline Intellectual Property Development Limited | 725 |
41 |
| Takeda Pharmaceutical Company Limited | 3110 |
41 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 2910 |
41 |
| Hoffmann-La Roche Inc. | 2498 |
37 |
| Bayer Pharma AG | 1130 |
37 |
| Vertex Pharmaceuticals Incorporated | 1522 |
36 |
| Jiangsu Hengrui Medicine Co., Ltd. | 809 |
36 |
| AstraZeneca AB | 3694 |
35 |
| Pfizer Inc. | 3450 |
35 |
| Janssen Pharmaceutica N.V. | 4696 |
34 |
| Other owners | 6028 |